Bioavailability and Risk Assessment of Orally Ingested Polycyclic Aromatic Hydrocarbons
Tóm tắt
Polycyclic aromatic hydrocarbons (PAHs) are a family of toxicants that are ubiquitous in the environment. These contaminants generate considerable interest, because some of them are highly carcinogenic in laboratory animals and have been implicated in breast, lung, and colon cancers in humans. These chemicals commonly enter the human body through inhalation of cigarette smoke or consumption of contaminated food. Of these two pathways, dietary intake of PAHs constitutes a major source of exposure in humans. Although many reviews and books on PAHs have been published, factors affecting the accumulation of PAHs in the diet, their absorption following ingestion, and strategies to assess risk from exposure to these hydrocarbons following ingestion have received much less attention. This review, therefore, focuses on concentrations of PAHs in widely consumed dietary ingredients along with gastrointestinal absorption rates in humans. Metabolism and bioavailability of PAHs in animal models and the processes, which influence the disposition of these chemicals, are discussed. The utilitarian value of structure and metabolism in predicting PAH toxicity and carcinogenesis is also emphasized. Finally, based on intake, disposition, and tumorigenesis data, the exposure risk to PAHs from diet, and contaminated soil is presented. This information is expected to provide a framework for refinements in risk assessment of PAHs from a multimedia exposure perspective.
Từ khóa
Tài liệu tham khảo
Autrup H, 1978, Cancer Res, 38, 3689
*Baird WM, 1997, Comprehensive toxicology, 12, 171
Benford DJ, 1985, Food toxicology—Real or imaginary problems?, 152
Bock KW, 1979, Med. Biol, 57, 262
Brandt HC, 2003, Ann. Occup. Hyg, 47, 349
Buckley TJ, 1992, Br. J. Ind. Med, 49, 113
Chae YH, 1993, Cancer Res, 53, 2028
Chen BH, 1997, J. Food Drug Anal, 5, 25
ChenCWChuMML1991Dose-response analysis of ingested benzo-a-pyrene. EPA/600/R-92/045United States Environmental Protection AgencyWashington. DC
Dai Q, 2001, Proc. Am. Assoc. Cancer Res, 42, 765
Davila DR, 1997, TEN, 4, 5
Dennis JM, 1983, Polynuclear aromatic hydrocarbons: Formation, metabolism, and measurement, 405
ECSCF, 2000, Background Document SCF/CS/CNTM/PAH/29 ADD1 Final. European Commission Scientific Committee on Food, 195
Eltom SE, 1999, Mol. Pharmacol, 55, 594
Fay MP, 1997, Cancer Res, 57, 3979
Gibaldi M, 1991, Biopharmaceutics and clinical pharmacokinetics
Goon D, 1991, Toxicologist, 11, 1356
Guigal N, 2001, Life. Sci, 68, 2141
Holman HYN, 1997, Annual Report, Earth Sciences Division, Lawrence Berkeley National Lab
Hrudey SE, 1996, Bioavailability in environmental risk assessment
IARC -International Agency for Research on Cancer-1983IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, polynuclear aromatic compounds, part I, chemical, environmental and experimental data323591International Agency for Research on CancerFrance
IatropolousMJ1986Gastrointestinal toxicologyRozmanKHannenenO246AmsterdamElsevier Science Publishers
IPCS, 1998, International Programme on Chemical Safety, World Health Organization
Josephy PD, 1997, Molecular toxicology
Kargman SL, 1995, Cancer Res, 55, 2556
Klein H, 1993, Bundesgesundheitsblatt, 36, 98
Larsen MC, 1998, Cancer Res, 58, 2366
Lin JH, 1999, Pharmacol. Rev, 51, 135
Mirvish SS, 1981, Cancer Res, 41, 2289
Moorthy B, 2002, J. Pharmacol. Exp. Ther, 294, 313
NEPI2000Assessing the bioavailability of organic chemicals in soil for use in human health risk assessmentsNational Environmental Policy InstituteWashington, DC
NRC, 2003, Bioavailability of contaminants in soils and sediments: Processes, tools and applications
Pfannhauser W, 1991, MittGeb Lebensmittelunters Hyg, 82, 66
Rabache M, 1985, Int. J. Vit. Nutr. Res, 55, 113
Rand GM, 1995, Fundamentals of aquatic toxicology
Rozett K, 1996, Toxicologist, 30, 324
Santodonato J, 1981, J. Environ. Pathol. Toxicol, 5, 1
Scherer G, 2000, Cancer Epidemiol. Biomarkers Prev, 9, 373
Selkirk JK, 1985, Carcinog. Compr. Surv, 10, 123
Shen Z, 1994, Cancer Res, 54, 4052
Shimada T, 1999, Rev. Toxicol, 3, 139
Shimada T, 1989, Cancer Res, 49, 6304
Shou M, 1994, Cancer Res, 54, 4052
Sinha R, 1999, Cancer Res, 59, 4320
U.S. Environmental Protection Agency1993Provisional guidance for quantitative risk assessment of polycyclic aromatic hydrocarbons. Final draft. ECAO-CIN-842Cincinnati, OHEnvironmental Criteria and Assessment Office, Office of Health and Environmental Assessment
Wang M, 1998, Cancer Res, 58, 38
Weyand EH, 1996, Toxicologist, 30, 321
WHO2003Selected nitro- and nitro-oxy-polycyclic aromatic hydrocarbons. Environmental Health Criteria. No. 229World Health OrganizationGeneva341
Wiersma DA, 1983, J. Pharmacol. Exp. Ther, 226, 661
Yun C-H, 1992, Cancer Res, 52, 1868
Zhang QY, 1996, Drug Metab. Dispos, 24, 322
Zhang QY, 1997, Drug Metab. Dispos, 25, 21
*Zhao W, 1995, Toxicol. In Vitro, 12, 395